The study of attributable causes of death (ACD) provides a new venue to quantify the external (nongenetic) causes of mortality, and may guide policymaking to address emerging issues in public health by focusing on the largely preventable risk factors. Given such importance, systematic methods to assess the variability of the attributable number of deaths (AND), including the standard errors and confidence intervals, need to be developed. In this article, we develop two statistical methods of the estimation of the standard errors and confidence intervals for the ANDs, one using multinomial distribution and the other using bootstrap sampling, and study the effect of the size of the mortality through simulations. Both methods are easy to implement and provide valid and efficient estimation of the standard errors and confidence intervals. While AND estimates and their standard errors increase with the size of the mortality, the ratio of the standard error to the AND estimate decreases. We demonstrate the methods with two data sets, the US national mortality data during the year 2006 and the mortality data of Chaoyang district of Beijing, China during the year 2007. We conclude that assessment of the variability is needed for small size mortality as the uncertainty is relatively large, but not for large size mortality.
Introduction
Premature death is one of the primary foci of public health concerns. Epidemiological studies of mortality data can help to guide policymaking to address emerging public health issues, by monitoring the dynamic trend of mortality of a given population over time and designing corresponding public health programs to reduce the risks that are largely preventable. So far, many intervention programs have proved to be successful, such as smoking cessation programs to prevent lung cancer, etc. However, it is known that diseases are often multifactorial, and that one single risk factor may contribute simultaneously to multiple diseases. Therefore, at the population level, intervention studies targeting a single disease may seem to be less effective than they actually are since other diseases not considered in the study programs may also benefit but are not accounted. For example, smoking cessation may prevent not only lung cancer, but also cardiovascular diseases. 1 Thus studies focusing on the primary prevention of lung cancer through smoking cessation programs may account for less benefit than its actual effect since the benefit on cardiovascular diseases is not accounted. Better understanding of the mechanism of how the risk factors lead to the diseases and death, particularly answers to the questions: "How many risk factors contribute to each disease?", "How do they interact?" and "How many diseases does each risk submit your manuscript | www.dovepress.com
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Fu et al factor contribute to?" will surely increase the likelihood of the success of the intervention programs. To achieve this, one needs valid estimation of the risk factors to each specific disease and also needs to assess the weight or proportion that is attributable to the risk factors.
In two pioneering articles, the attributable causes of death (ACDs) were studied for the US national mortality data. 2, 3 In these two articles, the authors named the external (nongenetic) risk factors of death or the ACDs, the actual causes of death. A recent ACD study incorporated further dietary factors into consideration. 4 These studies identified and quantified the major risk factors leading to a large portion of the US national mortality, including high blood pressure, tobacco use, alcohol consumption, poor diet and physical inactivity, etc. It was also noticed that these ACDs are largely preventable through intervention programs.
To identify and quantify the risk factors, one needs to study the mortality data and the population attributable fractions (PAFs) of the multiple risk factors for each given disease leading to death. [2] [3] [4] For a given population, the attributable number of deaths (AND) of a specific risk factor can be computed with the PAFs estimated with relative risks or the odds ratio of the diseases 3, 4 together with the population mortality data by disease, and a list of leading ACDs can then be generated. [2] [3] [4] The PAFs have been studied extensively for various types of study designs, including retrospective studies adjusting for confounding factors, 5 studies with stratified data, 6 studies based on logistic regressions, 7 unmatched case-control studies using logistic regression, 8 studies of fitted incidence ratios and exposure survey data, 9 and case-control studies with matched pairs, 10 etc. Based on the above methods, the World Bank conducted a risk factor study for many diseases leading to death among the worldwide population by gender, age group, and geographic region.
11
Although the mortality of large geographic regions, such as a metropolitan, a state or a country, is very often of interest to investigators, small geographic regions or regions with sparse population may also be of interest. 6 While the mortality in large populations and the estimated ANDs are in general stable and have relatively small variation, those in moderate size populations or smaller may present large variation. Thus it is of importance to study how the ANDs vary with the population size. Although the variability of the PAFs has been studied, [6] [7] [8] [9] [10] that of the ANDs has not been studied systematically. Specifically, the variability of the ANDs was not assessed in the two studies of US mortality 2,3 although large variability was not expected for such large mortality data. While confidence intervals were reported through a simulation approach accounting for the variability from the PAFs based on several assumptions of the distributions of the uncertainties, including normal, Chi-squares, binomial, and log-normal distributions, 4 the variability from the mortality data was not accounted for. In theory, the variability of the ANDs may be attributed to either the PAFs estimation, or the mortality, or both. In practice, it is even more important to assess the variability from the mortality data because the mortality data may vary largely from state to state, or from city to city, while the PAFs remain stable for the same population within a country or a geographic region. In particular, it is extremely important to gain a priori knowledge about when an assessment of the uncertainty or variability is needed and how the variability varies with the population size. It is noted that since the mortality data are archived data, their distribution may vary with the population of interest. Thus, it may be less apparent to assess the variability of the mortality and of the ANDs.
In this article, we develop two methods to assess the variability of the ANDs, a parametric method using multinomial distribution of the mortality data and a nonparametric method using bootstrap sampling method. This work is of particular importance in determining if the AND estimates require variability assessment and for what population size it becomes necessary. Through simulation studies, we examine the effect of the mortality size on the AND estimates and the variability. We illustrate the method with two mortality data sets and provide the estimate, standard error, and confidence interval for the leading ACDs of the mortality.
Methods
Mortality data
The national mortality data of the US during 2006 were obtained from the National Vital Statistics Reports on deaths for the year 2006 published by the Centers for Disease Control and Prevention. 12 Among all the diseases, we selected 16 leading causes of death (shown in Table 1 ) that have the PAFs in the World Bank report. 11 We used the mortality data of these 16 diseases only in this study.
The mortality data of Chaoyang District of Beijing, China during 2007 were analyzed and 19 diseases as the leading causes of death were reported in Wang et al (2009) for the study of actual causes of death in Chaoyang district of Beijing. 13 These diseases were selected to match the PAFs reported in the World Bank Report. Among them were malignant neoplasms, diseases of the heart, cerebrovascular
Statistical analysis
The AND (N f ) of each risk factor f in a given population was calculated by
ie, the number of deaths n i of each disease i, which is likely to be causal to the deaths, multiplied by its PAF (a i ).
3,4,13
The a i is the PAF to the given risk factor by disease i under consideration. This multiplication yielded the AND of the risk factor under consideration for disease i. The summation was over all possible diseases that were partially attributed to the risk factors of consideration, and yielded the total number of deaths in a given population attributable to the risk factor of consideration, namely, the AND. To calculate the standard error and the confidence interval attributable to the mortality, we noticed that the counts of deaths from K different diseases (n 1 , …, n K ) follow a multinomial distribution for a given fixed total number of deaths N = n 1 + … + n K with probability (p 1 , …, p K ) estimated by (n 1 /N, …, n K /N). The variance of n i is var(n i ) = Np i (1 -p i ) and the covariance between n i and n j is cov(n i , n j ) = -Np i p j for two different diseases i and j. Therefore, for a given risk factor of interest, let A = (a 1 , …, a K ) denote the PAFs for the K diseases. The AND N f = ∑ i i i n a has a variance of a quadratic form of a i and p i for given fixed PAFs A:
which is increasing with N. This provides an easyto-implement parametric method to calculate the variance of the AND of each risk factor, and the 95% confidence interval can be calculated as (N f -1.96 se, N f + 1.96 se), where se is the standard error of the N f , and is calculated as the squareroot of var(N f ). It is noted that equation (2) only accounts for the variation in the mortality data, but not in the PAFs.
The standard error and the confidence interval of the AND can also be calculated through the nonparametric bootstrap method with 200 bootstrap samples.
14 Each bootstrap sample was obtained through random sampling from the original data. Let S = {Y 1 , Y 2 , …, Y K } be a collection of counts of deaths from K diseases, with Y k = {k, …, k} being indices of n k deaths from disease k, k = 1, …, K. The total number of deaths in the given population was N = n 1 + n 2 + … + n K . Let S b be a bootstrap sample of S with b = 1, …, B. S b was obtained by the bootstrap sampling: a random sample {1, …, 1, 2, …, 2, …, K, …, K} of S with replacement. The following procedure was carried out to compute the bootstrap standard error and the confidence interval. For each bootstrap sample S b , the AND to the risk factor of consideration N fb , was calculated. The standard error of the AND (N f ) was computed to be the standard deviation of {N fb , b = 1, …, B} with B = 200. That is, SE(N f ) = SD (N f1 , …, N fB ). The lower and upper bounds of the 95% confidence interval were computed to be the 0.025 and 0.975 quantiles of {N fb , b = 1, …, B} with B = 200, respectively. We noticed that in general, 200 bootstrap samples is enough to yield accurate estimation for the variance and confidence interval. 14 
Simulation study
Ten diseases and ten risk factors were assumed in the simulation study. The number of deaths from each disease was specified to be random integers (10000, 14210, 23430, 253210, 34550, 634630, 34530, 25220, 23420, 84540). The PAFs were randomly generated fractions between 0 and 1 with the sum of the ten PAFs for each disease less than or equal to 1, and were kept fixed for the assessment of the variability attributable to the mortality. In the simulations, the sum of PAFs of a disease less than 1 indicates that some risk factors, that the disease is attributable to, may not be known or considered in the study. To examine the effect of the population size, we computed the AND estimates and their standard errors in a simulation study by varying the mortality size with a varying multiplier C valued at 0.0001, 0.001, 0.01, 0.1 and 1 so that the structure of the mortality data remains the same as real mortality data. For each value of C, we computed SE(N f ) for a given risk factor using the above methods with B = 200 for the bootstrap sampling, and the standard error SE(N f ) was computed for all ten risk factors. We report the AND estimate N f , its standard error SE(N f ) and the ratio SE(N f )/N f by the varying multiplier C. We also compare the two methods of computing the standard errors for the simulated data with C = 1 using the scatter plot. The software package R (R Development Core Team; Auckland, New Zealand) was used in this study for the statistical computation.
Results
effect of the mortality size on AND and the variability
The AND estimate N f increased proportionally with the constant C through the size N of the mortality as in the definition, and the standard error SE(N f ) also increased as in equation (2). Figure 1 illustrates the AND estimates of the ten risk factors ( Figure 1A ) and their standard errors ( Figure 1B) by the multiplier C from 0.0001 to 1 in log scale. It is noticed with equation (2) that the standard error increases proportionally with the square-root of N. While the increase of the standard error can be explained by the fact that the larger the mortality data, the larger the variability, this variability does not reflect the significance of the AND estimates since the AND also increased. In order to assess the significance of the estimates, one needs to examine the relative variability, eg, the ratio of the standard error to the estimate, which is inversely proportional to the square root of mortality size. We thus examined the ratio SE(N f )/N f with the multiplier C. Figure 2 illustrates the ratio SE(N f )/N f for these ten risk factors. It shows that unlike the estimates and their standard errors, the ratio SE(N f )/N f decreased with the scaling parameter C. This clearly indicates that the relative variability of the ACD estimates decreased quickly with the mortality size, and reflects the fact that the larger the sample size, the smaller the (relative) variability. Figure 3 illustrates the comparison of the standard errors SE(N f ) between the bootstrap method and the multinomial distribution method. It is clear that the standard errors barely differ between these two methods. The leading ACDs of the national mortality of the US in 2006 included high blood pressure, high cholesterol, low fruit and vegetable consumption, smoking, physical inactivity, and overweight and obesity. Table 2 displays the AND estimates, the bootstrap standard errors, and 95% confidence intervals. Table 3 further displays these separately for males and females. The standard errors are very small relative to the estimates and thus not needed in the analysis of the national mortality data of the US for the leading ACDs.
Mortality of Chaoyang district of Beijing, China during 2007
The overall leading ACDs of Chaoyang district in 2007 included high blood pressure, smoking, alcohol use, low fruit and vegetable consumption, high cholesterol, physical inactivity, and overweight and obesity. Table 4 displays by age and sex the leading ACDs and the AND estimates, their standard errors and the 95% confidence intervals. It is noted that in most age groups, the leading risk factors remained the same between male and female. It is also noted that alcohol use was more severe in the young population and became less severe in the senior population. It is further noted that although unprotected sex was among the leading ACDs for female groups of age 15-29 and 30-44 years old, the estimates were not statistically significant at P = 0.05 level, and thus was not alarming. This observation is consistent with the report by Wang et al 13 in 2009 and illustrates the importance of the standard error and the confidence interval for the AND estimates.
Discussion
Many leading causes of death, such as lung cancer and cardiovascular diseases, are multifactorial, which makes it difficult to address all related issues of the same disease at once in a conventional disease-based study. Besides, intervention studies aiming at preventing or lowering one risk factor for a specific disease may also alter the risk factors of other diseases not under consideration. Therefore, an intervention study (eg, smoking cessation program) focusing on one primary disease (eg, lung cancer) may underestimate the actual overall benefit (including effect on lung cancer, cardiovascular diseases, etc) 
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of the intervention program. It is thus of crucial importance to make public health policies based on study outcomes that consider multiple risk factors and multiple diseases simultaneously. The study of ACDs provides such a venue to study the nongenetic risk factors of death, where many risk factors are often found largely preventable. Despite the above advantages of the ACD studies, many quantitative methods remain to be developed, in particular, methods for systematic estimation of the standard errors and the confidence intervals of the ANDs. In this study, we developed two methods for the variance estimation of the AND, the first assumes the mortality data follow a multinomial distribution and the second takes a nonparametric bootstrap approach. Simulation studies show that both lead to valid estimation of the variance of the AND. Both methods are easy to implement through a standard Using the bootstrap method, we studied the effect of the size of the mortality data on the AND estimates and the standard errors through simulations. We found that unlike other statistical estimates that usually achieve small variability with large samples, the AND standard error increases with the size of mortality. However, it is more interesting to note that the SE:AND ratio decreases with the size of mortality, which reflects the fact that the larger the mortality sample, the more accurate the estimation. This seemingly confusing outcome can be explained as follows. In general, the variability of estimates decreases with sample size while the estimates themselves converge to true values as sample size increases, ie, the estimates become stable around the true values. Therefore, the ratio of standard error to estimate effectively decreases with the sample size. Similarly in the AND estimation, the ratio decreases although both the standard error and the estimate increase with the size of the mortality.
We further illustrated with two mortality data sets of different sizes, one large data set of the national mortality of the US during 2006 and one moderate size set of mortality data in Chaoyang District of Beijing, China in 2007. We found that for the large national mortality data of the US, the SE:AND ratios are very small and thus standard errors are not needed, while for the moderate size Chaoyang District mortality data, standard errors are needed for the AND estimates. In particular, the point estimate of the AND for the unprotected sex was ranked high in the female groups of age 15-30 years and 30-44 years, had a large standard error and was not statistically significant. Therefore, the ranking of unprotected sex as a leading ACD may require further investigation. This demonstrates the needs of the variability assessment of the AND estimates in studying small-to-moderate size mortality data.
In comparing the results of the two mortality data sets, we found that although China and the US have very distinct culture and food consumption, and are located geographically far apart, the patterns of the leading ACDs are surprisingly similar. The top ACDs include high blood pressure, smoking, low fruit and vegetable consumption, alcohol use, high cholesterol level, overweight and obesity, and physical inactivity, among others. In particular, high blood pressure was ranked number one in both studies.
In summary, the multinomial distribution-based estimation method and the bootstrap method for the standard errors and confidence intervals for the AND estimates are useful tools in the study of attributable causes of death, and may play an important role in epidemiological studies of mortality and risk factors.
